Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Withdraws Tamiflu European Application; Will Submit More Flu B Data

Executive Summary

Roche will submit additional Tamiflu data supporting the drug's efficacy against influenza B after withdrawing its European application for the neauraminidase inhibitor.

You may also be interested in...



Roche Xenical Patient Compliance Could Increase With New DTC Campaign

Roche will attempt to increase patient compliance for its obesity drug Xenical through a multi-faceted direct-to-consumer campaign.

Roche Xenical Patient Compliance Could Increase With New DTC Campaign

Roche will attempt to increase patient compliance for its obesity drug Xenical through a multi-faceted direct-to-consumer campaign.

Tamiflu DTC Ads Should Encourage Flu Vaccination, FDA's Jolson Suggests

Direct-to-consumer advertising for Roche/Gilead's Tamiflu should emphasize the importance of influenza vaccination, FDA Antiviral Drug Products Division Director Heidi Jolson, MD, said in a memo explaining FDA's rationale for approving the flu treatment.

UsernamePublicRestriction

Register

OM017181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel